Bemutatkozás
Neunos Ltd. was incorporated in 2018, building upon over 10 years of dedicated research in neuromodulation and Oscillotherapy™. The company develops a minimally-invasive, implantable seizure suppression system, the ISP™ SeizureStop™ device, designed to automatically detect and terminate epileptic seizures. This breakthrough solution utilizes patented Intersectional Short Pulse (ISP) stimulation and a complex mathematical model to provide continuously and autonomously tailored transcranial electrical stimulation. Beyond epilepsy, Neunos is actively exploring new opportunities and alternative perspectives to deepen knowledge in neuropsychiatric disorders and find non-pharmaceutical therapeutic approaches.
Hivatalos adatok
Név, adószám, cégjegyzékszám, alapítás, létszám, legutolsó árbevétel és státusz – nyilvános webes forrásokból, néhány másodperc alatt.
Szolgáltatások, tevékenységek
- Development of ISP™ SeizureStop™ device
- Development of Oscillotherapy™ technology
- Development of closed-loop platform technology for neurological episode detection
- Development of automated seizure termination systems
- Development of non-pharmaceutical therapeutic approaches for neuropsychiatric disorders
- Conducting human safety investigations for medical devices
- Conducting pilot clinical studies for medical devices
- Conducting pivotal clinical trials for medical devices
- Obtaining CE-mark for medical devices
- Obtaining FDA approval for medical devices